UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036803 |
|---|---|
| Receipt number | R000041937 |
| Scientific Title | The effect of lactulose on gasses emanating from skin surface. Randomized double-blind, placebo-controlled crossover study. |
| Date of disclosure of the study information | 2019/05/23 |
| Last modified on | 2020/06/03 10:21:01 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The effect of lactulose on gasses emanating from skin surface. Randomized double-blind, placebo-controlled crossover study.
Acronym
The effect of lactulose on gasses emanating from skin surface.
Scientific Title
The effect of lactulose on gasses emanating from skin surface. Randomized double-blind, placebo-controlled crossover study.
Scientific Title:Acronym
The effect of lactulose on gasses emanating from skin surface.
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To research effect of 4 g lactulose for ammonia emanating from skin surface.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Emission flux of ammonia from skin surface
Key secondary outcomes
Emission flux of gasses except ammonia from skin surface
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
Institution consideration
Blocking
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Intake of lactulose 4g/day for 2weeks
Interventions/Control_2
Intake of placebo for 2weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Healthy subject
Key exclusion criteria
1) Subjects with severe hepatic, renal, heart, gastrointestinal, cerebrovascular, endocrine, metabolic or infection diseases.
2) Subjects with the history of gastrointestinal resection.
3) Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease.
4) Subjects who use medicines or supplements that may influence feces frequency; e.g. antibiotics, probiotics, laxatives, antidiarrheals, fibers.
5) Subjects with milk allergy.
6) Subjects with lactose intolerance
7) Subjects who participate another study.
8) Subjects who are judged inappropriate for the study by the investigator or the physician.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Yoshika |
| Middle name | |
| Last name | Sekine |
Organization
Tokai University
Division name
Graduate School of Science
Zip code
259-1207
Address
4-1-1 Kitakaname, Hiratsuka-City, Kanagawa-Prefecture
TEL
0463-58-1211
sekine@keyaki.cc.u-tokai.ac.jp
Public contact
Name of contact person
| 1st name | Yoshika |
| Middle name | |
| Last name | Sekine |
Organization
Tokai University
Division name
Graduate School of Science
Zip code
259-1207
Address
4-1-1 Kitakaname, Hiratsuka-City, Kanagawa-Prefecture
TEL
0463-58-1211
Homepage URL
sekine@keyaki.cc.u-tokai.ac.jp
Sponsor or person
Institute
Tokai University
Institute
Department
Personal name
Funding Source
Organization
Morinaga Milk Industry Co., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
TOKAI DAIGAKU " hito wo taisho to suru kenkyu"ni kansuru rinriiinnkai
Address
4-1-1 Kitakaname, Hiratsuka-City, Kanagawa-Prefecture
Tel
0463-58-1211
sekine@keyaki.cc.u-tokai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 05 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
30
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2019 | Year | 04 | Month | 10 | Day |
Date of IRB
| 2019 | Year | 04 | Month | 22 | Day |
Anticipated trial start date
| 2019 | Year | 05 | Month | 24 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2019 | Year | 05 | Month | 20 | Day |
Last modified on
| 2020 | Year | 06 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041937
